The Relationship Between Renal Stones and Primary Aldosteronism.
Chang CK, Chang CC, Wu VC, Geng JH, Lee HY.
Front Endocrinol (Lausanne). 2022 Feb 9;13:828839. doi: 10.3389/fendo.2022.828839. eCollection 2022.
A case of nephrocalcinosis associated with primary aldosteronism.
Yasuda K, Sasaki K, Yamato M, Rakugi H, Isaka Y, Hayashi T.
Intern Med. 2012;51(6):625-7. doi: 10.2169/internalmedicine.51.6543. Epub 2012 Mar 15.
Recurrent calcium nephrolithiasis associated with primary aldosteronism.
Shey J, Cameron MA, Sakhaee K, Moe OW.
Am J Kidney Dis. 2004 Jul;44(1):e7-12. doi: 10.1053/j.ajkd.2004.03.037.
Calcium and the kidney--from stones to molecules.
Suki WN.
Verh K Acad Geneeskd Belg. 1990;52(3):203-21; discussion 221-3.
Considerations about the molecular basis of some kidney tubule disorders in relation to inbreeding and population displacement.
García-Nieto VM, Claverie-Martín F, Perdomo-Ramírez A, Cárdoba-Lanus E, Ramos-Trujillo E, Mura-Escorche G, Tejera-Carreño P, Luis-Yanes MI; el Grupo RenalTube.
Nefrologia (Engl Ed). 2020 Mar-Apr;40(2):126-132. doi: 10.1016/j.nefro.2019.08.004. Epub 2019 Nov 27.
Nephrocalcinosis: molecular insights into calcium precipitation within the kidney.
Sayer JA, Carr G, Simmons NL.
Clin Sci (Lond). 2004 Jun;106(6):549-61. doi: 10.1042/CS20040048.
Diphosphonate therapy in nephrocalcinosis.
McCredie DA, Powell HR, Rotenberg E.
Br J Urol. 1976 Apr;48(2):93-100. doi: 10.1111/j.1464-410x.1976.tb02988.x.
Renal calculi in primary hyperaldosteronism.
Kabadi UM.
Postgrad Med J. 1995 Sep;71(839):561-2. doi: 10.1136/pgmj.71.839.561.
Molecular physiology of renal chloride channels.
Steinmeyer K, Jentsch TJ.
Curr Opin Nephrol Hypertens. 1998 Sep;7(5):497-502. doi: 10.1097/00041552-199809000-00003.
A novel mutation of KCNJ1 identified in an affected child with nephrolithiasis.
Yang S, Yao G, Chen X, Shi H, Lou C, Ren S, Jiao Z, Wang C, Kong X, Wu Q.
BMC Nephrol. 2022 Jun 27;23(1):227. doi: 10.1186/s12882-022-02783-x.
